CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

SCAI Clinical Expert Consensus Statement on Cardiogenic Shock Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized Trial No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019

Original Research202012

JOURNAL:J Am Heart Assoc. Article Link

Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention

K Vaidya , BJ Cochran, S Patel et al. Keywords: colchicine; antiinflammatory effects; cardiovascular events; ACS

Full Text PDF